This increase in ethidium staining indicated a significant increase in cell death, which continued to escalate with higher antibody concentrations, reinforcing the potent killing effect of Cibisatamab on CEA-expressing tumor cells (Figure 2C). The gene discussed is CEACAM3; the disease is neoplasm.